Inactivation of the human vitamin D receptor by caspase-3

Endocrinology

Volumn 150, Issue 2, 2009, Pages 679-686

  Malloy, Peter J ^a   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CASPASE 3; CASPASE 6; CASPASE 7; STAUROSPORINE; VITAMIN D RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN LNCAP; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BINDING SITES; CASPASE 3; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, CALCITRIOL; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 59649129312     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1217     Document Type: Article

References (39)

1. Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR 2001 Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord 2:203-216
2. Stewart LV, Weigel NL 2004 Vitamin D and prostate cancer. Exp Biol Med (Maywood) 229:277-284
3. Nagpal S, Na S, Rathnachalam R 2005 Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662-687
4. Feldman D, Malloy PJ, Krishnan AV, Balint E 2007 Vitamin D: biology, action, and clinical implications. In: Marcus R, Feldman D, Nelson DA, Rosen CJ, eds. Osteoporosis. 3rd ed. San Diego: Academic Press; 317-382
5. Deeb KK, Trump DL, Johnson CS 2007 Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684-700
6. Krishnan AV, Moreno J, Nonn L, Malloy P, Swami S, Peng L, Peehl DM, Feldman D 2007 Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer. J Steroid Biochem Mol Biol 103:694-702
7. 2D3 resistance in mammary cells. J Steroid Biochem Mol Biol 103:703-707
8. Valrance ME, Brunet AH, Acosta A, Welsh J 2007 Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells. J Cell Biochem 101:1505-1519
9. Narvaez CJ, Welsh J 2001 Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem 276:91019107
10. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, GhayurT,BradyKD, Wong WW 1997 Substrate specificities of caspase family proteases. J Biol Chem 272:9677-9682
11. Stennicke HR, Renatus M, Meldal M, Salvesen GS 2000 Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem J 350(Pt 2):563-568
12. Stennicke HR, Ryan CA, Salvesen GS 2002 Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem Sci 27:94-101
13. Degterev A, Boyce M, Yuan J 2003 A decade of caspases. Oncogene22:8543-8567
14. Cohen GM 1997 Caspases: the executioners of apoptosis. Biochem J 326(Pt1):1-16
15. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P 2007 Caspases in cell survival, proliferation and differentiation. Cell Death Differ 14:44-55
16. Chau BN, Borges HL, Chen TT, Masselli A, Hunton IC, Wang JY 2002 Signal-dependent protection from apoptosis in mice expressing caspaseresistant Rb. Nat Cell Biol 4:757-765
17. Sayan BS, Sayan AE, Knight RA, Melino G, Cohen GM 2006 p53 is cleaved by caspases generating fragments localizing to mitochondria. J Biol Chem 281:13566-13573
18. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254
19. Marcelli M, Marani M, Li X, Sturgis L, Haidacher SJ, Trial JA, Mannucci R, Nicoletti I, Denner L 2000 Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine- induced apoptosis, expression of Bcl-2 family members, and caspase activation. Prostate 42:260-273
20. L underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res 61:1699-1706
21. Malloy PJ, Xu R, Peng L, Clark PA, Feldman D 2002 A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Mol Endocrinol 16:2538-2546
22. Malloy PJ, Eccleshall TR, Gross C, Van Maldergem L, Bouillon R, Feldman D 1997 Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest 99:297-304
23. Kuranaga E, Miura M 2007 Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol 17:135-144
24. Marcelli M, Cunningham GR, Walkup M, He Z, Sturgis L, Kagan C, Mannucci R, Nicoletti I, Teng B, Denner L 1999 Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpres- sionofcaspase-7asanewgenetherapystrategyforprostatecancer.Cancer Res 59:382-390
25. Brophy VA, Tavare JM, Rivett AJ 2002 Treatment of COS-7 cells with protea- some inhibitors or γ-interferon reduces the increase in caspase 3 activity associated with staurosporine-induced apoptosis. Arch Biochem Biophys 397:199-205
26. Tozser J, Bagossi P, Zahuczky G, Specht SI, Majerova E, Copeland TD 2003 Effect of caspase cleavage-site phosphorylation on proteolysis. Biochem J372:137-143
27. Belizario JE, Alves J, Garay-Malpartida M, Occhiucci JM 2008 Coupling caspase cleavage and proteasomal degradation of proteins carrying PESTmo- tif. Curr Protein Pept Sci 9:210-220
28. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D 2000 The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 5:173-179
29. Rochel N, Tocchini-Valentini G, Egea PF, Juntunen K, Garnier JM, Vihko P, Moras D 2001 Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor. Eur JBiochem 268:971-979
30. An S, Park MJ, Park IC, Hong SI, Knox K 2003 Procaspase-3 and its active large subunit localized in both cytoplasm and nucleus are activated following application of apoptotic stimulus in Ramos-Burkitt lymphoma B cells. Int J Mol Med 12:311-317
31. Mathiasen IS, Lademann U, Jaattela M 1999 Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res 59:4848-4856
32. Guzey M, Kitada S, Reed JC 2002 Apoptosis induction by 1α,25-dihydroxyvitamin D3 in prostate cancer. Mol Cancer Ther 1:667-677
33. Polek TC, Stewart LV, Ryu EJ, Cohen MB, Allegretto EA, Weigel NL 2003 p53 is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells. Endocrinology 144:50-60
34. 2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol Endocrinol 21:334-342
35. 2D3-induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol 265266:168-173
36. Ly LH, Zhao XY, Holloway L, Feldman D 1999 Liarozole acts synergistically with 1α,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 140:20712076
37. Perwad F, Zhang MY, Tenenhouse HS, Portale AA 2007 Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1α-hydroxylase expression in vitro. Am J Physiol Renal Physiol 293:1577-1583
38. Masuyama H, MacDonald PN 1998 Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR. J Cell Biochem 71:429-440
39. LiXY,Boudjelal M, Xiao JH, Peng ZH, Asuru A, Kang S, Fisher GJ, Voorhees JJ 1999 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol Endocrinol 13:1686-1694